| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 03/22/2000 | EP0987275A2 Molecules that home to a selected organ or tissue in vivo and methods of identifying same |
| 03/22/2000 | EP0987265A1 Interleukin-5 inhibiting 6-azauracil derivatives |
| 03/22/2000 | EP0986373A1 Drug targeting system, method of its preparation and its use |
| 03/22/2000 | EP0860170B1 Tablets based on isotope-labeled urea |
| 03/21/2000 | US6040432 Metal complexes, of DTPA derivatives suitable for use in diagnosis and therapy |
| 03/21/2000 | US6040290 Antitumor agents for inhibiting the growth of adenocarcinoma cells |
| 03/16/2000 | WO2000014537A2 Immunoconjugate for diagnosis of multidrug resistance |
| 03/16/2000 | WO2000014119A2 Bifunctional antibodies and their use in targeting anti-tumour agents |
| 03/16/2000 | WO2000013677A1 Nanogel networks and biological agent composition thereof |
| 03/16/2000 | WO1999064047A9 Novel antiviral compounds |
| 03/16/2000 | WO1999063929A9 Multibinding inhibitors of microsomal triglyceride transferase protein |
| 03/16/2000 | WO1999058570A3 Antibodies to the ed-b domain of fibronectin, conjugates containing them and use therefor for diagnosis and therapy of tumors and diseases associated with angiogenesis |
| 03/16/2000 | WO1999057151A3 FAP α-SPECIFIC ANTIBODY WITH IMPROVED PRODUCIBILITY |
| 03/16/2000 | WO1999055385A3 Radioimmunopharmaca for treating hepatitis c |
| 03/16/2000 | CA2342800A1 Nanogel networks and biological agent composition thereof |
| 03/16/2000 | CA2341753A1 Bifunctional antibodies and their use in targeting anti-tumour agents |
| 03/15/2000 | EP0984791A1 Ternary ligand complexes useful as radiopharmaceuticals |
| 03/15/2000 | EP0641358B1 BINDING PEPTIDES WHICH INTERACT WITH LIGAND GROWTH FACTORS OF THE EPIDERMAL GROWTH FACTOR RECEPTOR AND erbB-2-RECEPTOR |
| 03/14/2000 | US6037494 Crystallizing pure iopamidol from the alcohol solvents which give azeotropes with water forming two separate layers; lower has minimal removable solvent content, and upper layer can be recycled to reduce amount of solvent used |
| 03/14/2000 | US6036955 Antitumor agents |
| 03/14/2000 | CA2125895C Heteroatom-bearing ligands and metal complexes thereof |
| 03/09/2000 | WO2000012758A1 A novel method of diagnosing, monitoring, staging, imaging and treating various cancers |
| 03/09/2000 | WO2000012536A2 Lipid matrix-assisted chemical ligation and synthesis of membrane polypeptides |
| 03/09/2000 | WO2000012493A1 Thiazoline acid derivatives |
| 03/09/2000 | DE19838183A1 Verfahren zur Herstellung von Gegenständen mit einer gekapselten Radioaktivität, insbesondere bei medizinischen Implantaten A process for the production of articles with an encapsulated radioactivity, particularly in medical implants |
| 03/09/2000 | CA2351547A1 Lipid matrix-assisted chemical ligation and synthesis of membrane polypeptides |
| 03/09/2000 | CA2341142A1 A novel method of diagnosing, monitoring, staging, imaging and treating various cancers |
| 03/07/2000 | US6034223 Non-peptidyl moiety-conjugated CD4-gamma2 and CD4-IgG2 immunoconjugates, and uses thereof |
| 03/07/2000 | US6033645 Methods for diagnostic imaging by regulating the administration rate of a contrast agent |
| 03/07/2000 | US6033644 Biomodulators as universal imaging agents |
| 03/02/2000 | WO2000010615A1 Method for producing objects containing encapsulated radioactive elements, notably for medical implants |
| 03/02/2000 | WO2000010614A1 METHODS FOR LABELING β-AMYLOID PLAQUES AND NEUROFIBRILLARY TANGLES |
| 03/02/2000 | WO2000010609A1 Targeting of molecules to large vessel endothelium using epcr |
| 03/02/2000 | WO1999064054A9 Multibinding inhibitors of topoisomerase |
| 03/02/2000 | WO1999064043A9 Muscarinic receptor antagonists |
| 03/02/2000 | WO1999063937A3 Multivalent macrolide antibiotics |
| 03/02/2000 | WO1999059640A3 Metal complexes derivatized with folate for use in diagnostic and therapeutic applications |
| 03/02/2000 | CA2341586A1 Targeting of molecules to large vessel endothelium using epcr |
| 03/02/2000 | CA2340394A1 Methods for labeling .beta.-amyloid plaques and neurofibrillary tangles |
| 03/01/2000 | EP0981728A2 Radiolabeled farnesyl-protein transferase inhibitors |
| 03/01/2000 | EP0981369A2 Immunogenic compositions to the cck-b/gastrin-receptor and methods for the treatment of tumors |
| 03/01/2000 | EP0759913B1 Aromatic amine substituted bridged nitrogen and sulfur donor atom ligands for imaging |
| 03/01/2000 | EP0594739B1 Cancer treatment |
| 03/01/2000 | CN1246033A Hexahydroindenopyridine compounds having antispermatogenic activity |
| 02/29/2000 | CA2248592A1 Microspheres for use in the treatment of cancer |
| 02/29/2000 | CA2093928C Monoclonal antibodies for detection and treatment of cancer |
| 02/29/2000 | CA2033347C Monoclonal antibodies against leukocyte adhesion receptor beta-chain, methods of producing these antibodies and use therefore |
| 02/24/2000 | WO2000009169A1 Non-porphyrin compound for use as a diagnosticum and/or pharmaceutical |
| 02/24/2000 | WO2000009160A1 Combination therapies for b-cell lymphomas comprising administration of anti-cd20 antibody |
| 02/24/2000 | WO2000009155A1 Methods and compositions for preventing anti-gal production in xenograft recipients |
| 02/24/2000 | WO2000009076A2 Imaging with tc-99m labeled fibrin-alpha-chain peptide |
| 02/24/2000 | CA2348617A1 Imaging with tc-99m labeled fibrin-alpha-chain peptide |
| 02/24/2000 | CA2340091A1 Combination therapies for b-cell lymphomas comprising administration of anti-cd20 antibody |
| 02/23/2000 | EP0980441A1 Methods for measuring cellular proliferation and destruction rates in vitro and in vivo |
| 02/23/2000 | EP0980274A2 Polymer-coated stents, processes for producing the same and their use for restenosis prevention |
| 02/22/2000 | US6028056 Useful for in vivo detection and diagnosis of thrombi. the precursor reagents of the invention may also be used in production of antithrombotic agents derived from apcitide |
| 02/22/2000 | US6027711 Structurally determined metallo-constructs and applications |
| 02/22/2000 | US6027710 Protects the active ingredient of radiopharmaceuticals against the radiolysis caused by a reaction of the active ingredient with water radicals formed by radiolysis without decomposing the reactive active ingredient (reducible) |
| 02/22/2000 | CA2004532C Peptide derivatives |
| 02/17/2000 | WO2000008651A2 Palladium coated implant |
| 02/17/2000 | WO2000008210A1 A novel method of diagnosing, monitoring, staging, imaging and treating breast cancer |
| 02/17/2000 | WO2000008206A1 A novel method of diagnosing, monitoring, staging, imaging and treating lung cancer |
| 02/17/2000 | WO2000007632A1 A novel method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 02/17/2000 | WO2000007625A1 Targeting and prolonging association of drugs to the luminal surface of the pulmonary vascular endothelial cells |
| 02/17/2000 | WO2000000223A3 ANTIVIRAL AND ANTIRETROVIRAL RADIOIMMUNOMEDICAMENTS BASED ON α-EMITTERS AND β-EMITTERS |
| 02/17/2000 | WO1999045969A3 Radioimmuno-pharmacon for treating the hiv-1 infection |
| 02/17/2000 | CA2348151A1 A novel method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 02/17/2000 | CA2347906A1 A novel method of diagnosing, monitoring, staging, imaging and treating breast cancer |
| 02/17/2000 | CA2347656A1 A novel method of diagnosing, monitoring, staging, imaging and treating lung cancer |
| 02/16/2000 | EP0979656A2 Composition containing radioisotopes immobilised on solid particles, and its use in brachytherapy |
| 02/16/2000 | EP0979513A1 PROCESS AND APPARATUS FOR THE PRODUCTION OF Bi-212 AND A USE THEREOF |
| 02/16/2000 | EP0979122A1 Targeted therapy to a biomedical device |
| 02/16/2000 | EP0979108A2 Stents with a radioactive surface coating, processes for producing the same and their use for restenosis prevention |
| 02/15/2000 | US6026317 Myocardial perfusion imaging during coronary vasodilation with selective adenosine A2 receptor agonists |
| 02/15/2000 | US6024938 Lyophilized imaging agent formulation comprising a chemotactic peptide |
| 02/15/2000 | US6024937 Targets of proteins, biotin and hydrolyzable group of imide, ester or carbamate |
| 02/15/2000 | CA1340899C Procede de preparation de complexes nitruro 99m tc, 186 re ou 188 re utilisables comme produits radiopharmaceutiques |
| 02/10/2000 | WO2000006243A2 Absorbable brachytherapy and chemotherapy delivery devices and methods |
| 02/10/2000 | WO1999062563A3 Radiolabeled peptides for the diagnosis and treatment of breast and prostate tumors and metastases of such tumors |
| 02/10/2000 | WO1999058139A3 Methods for detecting and inhibiting angiogenesis |
| 02/10/2000 | WO1999049899A3 Diagnostic imaging of vascular abnormalities using vasomodification |
| 02/10/2000 | WO1999036105A3 USE OF RADIOLABELED MONOCLONAL IgM IN THERAPY FOR CANCER AND AUTOIMMUNE DISEASE |
| 02/10/2000 | WO1999023104A3 Antitumour uridine analogues |
| 02/09/2000 | EP0977600A2 Contrast agents |
| 02/09/2000 | EP0977593A1 Embolus therapy using insoluble microparticles or vesicles containing contrast agents |
| 02/09/2000 | EP0977579A1 Gastrin receptor-avid peptide conjugates |
| 02/08/2000 | US6022857 Radiolabeled compounds for thrombus imaging |
| 02/08/2000 | US6022541 Immunological preparation for concurrent specific binding to spatially exposed regions of vascular permeability factor bound in-vivo to a tumor associated blood vessel |
| 02/08/2000 | US6022523 Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders |
| 02/08/2000 | US6022522 Rigid bifunctional chelating agents |
| 02/08/2000 | US6022521 Establishing a given centigray (cgy) dose to either the patient's lean body or the patient's total body |
| 02/08/2000 | US6022520 Administering a diagnostic amount of a radiolabeled reagent capable of inhibiting human platelet aggregation comprising radiolabel complexing moiety and a platelet glycoprotein iib/iiia-binding compound covalently linked to the moiety |
| 02/08/2000 | CA2199945C X-ray emitting interstitial implants |
| 02/08/2000 | CA2095832C Molecular sieve-enclosed transition and rare earth metal ions as contrast agents for the gastrointestinal tract |
| 02/03/2000 | WO2000004954A2 Novel urokinase inhibitors |
| 02/03/2000 | WO2000004868A2 Libraries of polyhydroxamates and their analogs |
| 02/03/2000 | WO1999063929A3 Multibinding inhibitors of microsomal triglyceride transferase protein |
| 02/03/2000 | WO1999061097A3 Alpha emitting constructs and uses thereof |
| 02/03/2000 | WO1999058149B1 Controlled activation of targeted radionuclides |
| 02/03/2000 | CA2337756A1 Libraries of polyhydroxamates and their analogs |